SG biotech startup Amili raises $10.5m in Series A funding
AsiaTechDaily
JUNE 15, 2022
Bookmark ( 0 ) Please login to bookmark Username or Email Address Password Remember Me No account yet? Register Amili , a Singapore-based precision gut microbiome startup , has raised $10.5 million in Series A funding. This round was led by Vulcan Capital, the investment arm of late Microsoft Corp Co-Founder Paul Allen, which invests in category-leading technology, internet, and life sciences firms.
Let's personalize your content